Mismatch Repair Protein (MSH2) Novocastra
Human mismatch repair protein 2 (MSH2) is involved in the initial recognition of mismatched nucleotides during the post replication mismatch repair process. Therefore, the loss of MSH2 function leads to the accumulation of replication errors, which in turn may be responsible for the multiple mutations required for multistage carcinogenesis. MSH2 is reported to be expressed in the nuclei of cells from a variety of tissues including thyroid, heart, smooth muscle and the germinal centers of lymphoid follicles. In ileum and colon, MSH2 expression has been reported in the crypts, the cells which are undergoing rapid renewal. They are responsible for the continuous production of differentiated cells which migrate over 2 to 4 days before being sloughed into the lumen.
|PA0048||7ml MSH2 Bond RTU Primary||Bond ready to use reagent||P(HIER)||Info||MSDS||1|
|MSH2-L-CE||1ml NCL-L-MSH2||Liquid Concentrated Monoclonal Antibody||P(HIER)||Info||MSDS||1|
|MSH2||1ml NCL-MSH2||Lyophilised Concentrated Monoclonal Antibody||P(HIER)||Info||MSDS||1|
|MSH2-CE||1ml NCL-MSH2||Lyophilised Concentrated Monoclonal Antibody||P(HIER)||Info||MSDS||1|
|MSH2-CE-S||0.1ml NCL-MSH2||Lyophilised Concentrated Monoclonal Antibody||P(HIER)||Info||MSDS||1|